Research ID
hum0006-v1Release info
Research title
Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance
Research overview
- Aims
- The identification of genomic/genetic alterations in brain tumors (gliomas) and analysis of their clinicopathological significance.
- Methods
- Exome sequence analysis using next generation sequencer (Illumina HiSeq 2000).
- Participants/materials
- Surgical specimen of brain tumors (gliomas) and parid normal peripheral blood cells (Total: 23 samples).
- URL
- N/A
Datasets
The list is the one this version published; each dataset's content is shown as it is now.
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000004 | astrocytoma NGS (Exome) |
| Controlled-access (Type I) | 2020-09-28 |
Data provider
- Principal investigator
- Nobuhito Saito
- Affiliation
- Department of Neurosurgery, The University of Tokyo
Research projects
| Name | URL |
|---|---|
Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) |
Grants
| Name | Title | Project number |
|---|---|---|
Ministry of Education, Culture, Sports, Science and Technology Japan (MEXT) P-DIRECT | Development of novel therapeutic strategy and biomarker for the treatment of malignant brain tumors | N/A |
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma |
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 | |
| Frank Attenello | Department of Neurological Surgery, USC Keck School of Medicine | United States | Examining the role of a novel long noncoding RNA, linc02454, in resistance of glioblastoma to temozolomide | 2023-04-06 – 2026-01-31 |